Why the study?
The increasing incidence and mortality of colorectal cancer in Chile and worldwide have stimulated efforts to better understand the inflammatory mediators influencing tumor progression and patient evolution.
Answers are grounded in this paper and cite their sources.
Inflammatory mediators such as TNF-alpha, IL-6, and the IL-33/ST2 pathway modulate the tumor microenvironment and influence the progression and evolution of colorectal cancer.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
L et al. (2017) conducted a review in Colorectal cancer. Inflammatory mediators (TNF-a, IL-6, IL-33/ST2) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: